Conquer Cancer Logo

The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. Applications in all areas of cancer research are accepted from U.S. and international applicants.

The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants who are selected to receive a YIA are allowed to receive other grants from other funding agencies.

*We are currently accepting applications for the 2021 Conquer Cancer – Lobular Breast Cancer Alliance Young Investigator Award for Invasive Lobular Carcinoma Research.​ Information regarding 2022 YIA competitions will be posted in June.* 


Applicants must meet the following criteria to qualify for a YIA:

  • Be a physician (MD, DO, or international equivalent) working in any country and currently in the last two years of his/her final subspecialty training at an academic medical institution and within 10 years of obtaining his/her medical degree at the time of grant submission. Examples of subspecialty training include, but are not limited to, a hematology-oncology fellowship, a surgical oncology fellowship, or a radiation oncology residency. An MD, PhD is eligible if both degrees are completed prior to the start of the grant period.
  • Be planning an investigative career in clinical oncology.
  • Have a valid, active medical license in the country where the research will be conducted at the time of application.
  • An institutional commitment for a faculty appointment at the time of grant submission is not required, but the applicant should be working in an oncology laboratory or clinical research setting.
  • Have a mentor in the proposed research field from the sponsoring institution. The mentor must assume responsibility and provide guidance for the research. If the mentor is not an ASCO member, a supporting letter from an ASCO member from the sponsoring institution must be included.
  • Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, go to
  • Be able to commit at least 60% of full-time effort in research (applies to total research, not just the proposed project) during the award period.
  • Eligible physicians are allowed to hold only one grant from the Conquer Cancer Foundation at a time.

Funding Available

The number of YIAs funded each year is not predetermined by Conquer Cancer. Awards are given based on individual merit and availability of funds.

Areas with Endowed and Dedicated Funding*

Conquer Cancer has endowed funding for certain areas that allows us to fund grants in these areas year after year. For 2021, dedicated funding is available in, but not limited to, the areas listed below. This list will be updated as new funding is confirmed. Conquer Cancer encourages applications in ALL areas of cancer research from U.S. and international applicants. 

Open Competitions

  • Conquer Cancer – Lobular Breast Cancer Alliance Young Investigator Award for Invasive Lobular Carcinoma Research (Request for Proposals)
    • Application Open: April 1, 2021
    • Application Due: May 21, 2021

Closed Competitions

  • Endowed Young Investigator Award in Breast Cancer in Memory of Evelyn H. Lauder
  • Young Investigator Awards in Breast Cancer
  • Young Investigator Awards for Diversity, Inclusion and Breast Cancer Disparities 
  • Young Investigator Award for a Florida-based Investigator
  • Boehringer Ingelheim Endowed Young Investigator Award in Gastrointestinal Cancers or Lung Cancer
  • Endowed Young Investigator Award in Geriatric Oncology in Honor of Dr. Arti Hurria 
  • Young Investigator Award in Glioblastoma 
  • Novartis Endowed Young Investigator Award in Health Disparities
  • Young Investigator Award for a Northern California-based Investigator
  • Young Investigator Award in Primary Brain Tumor
  • Young Investigator Awards in Sarcoma 
  • Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care 
  • Bristol-Myers Squibb Endowed Women Who Conquer Cancer Young Investigator Award
  • Conquer Cancer Endowed Women Who Conquer Cancer Young Investigator Award
  • Dr. Jose Leis Endowed Young Investigator Award in Chronic Lymphocytic Leukemia 
  • Frist Family Endowed Young Investigator Award in Mantle Cell Lymphoma in Honor of Howard A. Burris, III, MD 
  • Young Investigator Award in Mesothelioma
  • Young Investigator Award in Ovarian Cancer 

*As of April 1, 2021.

Application Instructions

All application materials must be in English and must be submitted through the Application Portal. Paper applications or applications sent by e-mail or fax will not be accepted.

Open: Apply by May 21, 2021.

Application Deadlines

Application Open: 

April 1, 2021

Letter of Intent Deadline: 

Application Deadline: 

May 21, 2021

Award Term: 

August 1, 2021 to July 31, 2022


The Young Investigator Awards are supported by:

Logo for Lobular Breast Cancer Alliance


ASCO State Affiliate Council and ASCO Clinical Practice Committee
Charles M. Baum, MD, PhD
Nina Lesavoy Brady
Howard A. Burris, III, MD and Karen Y. Burris
Dr. and Mrs. Thomas F. Frist, Jr., Mr. and Mrs. Charles and Trisha Elcan,  Howard A. Burris, III, MD, and Sarah Cannon Research Institute
Friends and Family of Dr. Arti Hurria
Judith Salmon Kaur, MD
Helen L. Kay Charitable Trust
Leap Therapeutics, Inc.
Georgia and Michael Michelson
Victoria H. Montgomery
Nebraska Oncology Society
Northern New England Clinical Oncology Society
Greg Parekh/ New Rhein Healthcare, LLC
Thomas G. Roberts, Jr., MD, FASCO and Susan M. DaSilva, PhD
Sapiente Family Foundation
Aaron and Barbro Sasson
Shanken Family Foundation
Stephen A. Sherwin, MD
Tennessee Oncology
Tomasello Family
Wawa Foundation
Generous Supporters of the Women Who Conquer Cancer

This list reflects commitments as of April 6, 2021.

This grant receives support that may result in a report to the CMS Open Payments website under the Physician Payments Sunshine Act. The supporting companies are required to report the amount of the grant, the names of physicians who are awarded this grant, and the names of their institutions. This information may appear on the Open Payments website. Find out more information about the Sunshine Act and CMS Open Payments program.